In addition to its ribonuclease capacity, RNASET2 has been reported to exert anti-angiogenic and anti-tumorigenic effects in several tumor cell lines, such as colon cancer, breast cancer, and ovarian cancer (10, 11). Here, RNASET2 is linked to colonic neoplasm.